Fat loss increases adiponectin,12 which regulates glucose levels and fatty acid breakdown and reverses insulin resistance.13 In the ipragliflozin group, adiponectin levels increased from baseline, a result which may have been associated with reduced fasting insulin levels and reduced HOMA‐R, a marker of insulin resistance in the present study. The gene discussed is ADIPOQ; the disease is Insulin resistance.